Evidence map›Paper›PMID 26901835›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2016

Adapting coculture in vitro models of the blood-brain barrier for use in cancer research: maintaining an appropriate endothelial monolayer for the assessment of transendothelial migration.

Elodie Vandenhaute, Aurore Drolez, Emmanuel Sevin, Fabien Gosselet, Caroline Mysiorek, Marie-Pierre Dehouck

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. A Biomimetic Human Multi-Cellular In Vitro Model of the Blood-Brain Barrier.International journal of molecular sciences · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Transport study of interleukin-1 inhibitors using a humanBrain, behavior, & immunity - health · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Materials for blood brain barrier modelingMaterials science & engineering. R, Reports : a review journal · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Elodie VandenhauteLaboratoire de la Barrière Hémato-Encéphalique-EA 2465, Faculté des Sciences Jean Perrin, Université d'Artois, LBHE, Lens, France.ORCID 0000-0003-2766-0052
Aurore DrolezLaboratoire de la Barrière Hémato-Encéphalique-EA 2465, Faculté des Sciences Jean Perrin, Université d'Artois, LBHE, Lens, France.
Emmanuel SevinLaboratoire de la Barrière Hémato-Encéphalique-EA 2465, Faculté des Sciences Jean Perrin, Université d'Artois, LBHE, Lens, France.
Fabien GosseletLaboratoire de la Barrière Hémato-Encéphalique-EA 2465, Faculté des Sciences Jean Perrin, Université d'Artois, LBHE, Lens, France.
Caroline MysiorekLaboratoire de la Barrière Hémato-Encéphalique-EA 2465, Faculté des Sciences Jean Perrin, Université d'Artois, LBHE, Lens, France.
Marie-Pierre DehouckLaboratoire de la Barrière Hémato-Encéphalique-EA 2465, Faculté des Sciences Jean Perrin, Université d'Artois, LBHE, Lens, France.
Université d'Artois · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although brain metastases are the most common brain tumors in adults, there are few treatment options in this setting. To colonize the brain, circulating tumor cells must cross the blood-brain barrier (BBB), which is situated within specialized, restrictive microvascular endothelium. Understanding how cancer cells manage to transmigrate through the BBB might enable this process to be prevented. In vitro models are dedicated tools for characterizing the cellular and molecular mechanisms that underlie transendothelial migration process, as long as they accurately mimic the brain endothelium's in vivo characteristics. The objective of the present study was to adapt an existing in vitro model of the human BBB for use in studying cancer cell transmigration. The model is based on the coculture of endothelial cells (ECs, derived from cord blood hematopoietic stem cells) and brain pericytes. To allow the migration of cancer cells into the lower compartment, our model had to be transposed onto inserts with a larger pore size. However, we encountered a problem when culturing ECs on large (3-μm)-pore inserts: the cells crossed the membrane and formed a non-physiological second layer on the lower face of the insert. Using 3-μm-pore inserts (in a 12-well plate format), we report here on a method that enables the maintenance of a single monolayer of ECs on the insert's upper face only. Under these chosen conditions, the ECs exhibited typical BBB properties found in the original model (including restricted paracellular permeability and the expression of continuous tight junctions). This modified in vitro model of the human BBB enabled us to investigate the migratory potential of the MDA-MB-231 cell line (derived from highly metastatic human breast cancer cells). Last, the results obtained were compared with the rate of transmigration through endothelia with no BBB features.

Indexed as

Blood-Brain BarrierBrain NeoplasmsBreast NeoplasmsCell Line, TumorCoculture TechniquesEndothelium, VascularFemaleHumansHuman Umbilical Vein Endothelial CellsModels, BiologicalNeoplastic Cells, CirculatingPericytesPorosityTransendothelial and Transepithelial Migration

Identifiers

PMID26901835
OpenAlexW2287103293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.